{
  "solution_stats": {
    "total_solutions": 14,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 4
      },
      {
        "solution_id": 2,
        "steps_count": 6
      },
      {
        "solution_id": 3,
        "steps_count": 2
      },
      {
        "solution_id": 4,
        "steps_count": 5
      },
      {
        "solution_id": 5,
        "steps_count": 3
      },
      {
        "solution_id": 6,
        "steps_count": 4
      },
      {
        "solution_id": 7,
        "steps_count": 3
      },
      {
        "solution_id": 8,
        "steps_count": 3
      },
      {
        "solution_id": 9,
        "steps_count": 6
      },
      {
        "solution_id": 10,
        "steps_count": 6
      },
      {
        "solution_id": 11,
        "steps_count": 3
      },
      {
        "solution_id": 12,
        "steps_count": 5
      },
      {
        "solution_id": 13,
        "steps_count": 6
      },
      {
        "solution_id": 14,
        "steps_count": 7
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule42",
              "prover9": "(-(-A3 -> A4) -> A5)",
              "prover9_expression": "(-(-has_funding(research_lab, project_alpha) -> receives_grant(research_lab, government_agency)) -> terminated_grant(government_agency, research_lab))",
              "natural": "In case it is not the case that the negation of the research lab having funding for project alpha leads to the research lab receiving a grant from the government agency, then the government agency terminated the grant to the research lab."
            },
            {
              "id": "Rule43",
              "prover9": "(-(-A3 -> A4) -> -A5)",
              "prover9_expression": "(-(-has_funding(research_lab, project_alpha) -> receives_grant(research_lab, government_agency)) -> -terminated_grant(government_agency, research_lab))",
              "natural": "Assuming it is not the case that the negation of the research lab having funding for project alpha implies the research lab receives a grant from the government agency, then it is not the case that the government agency terminated the grant to the research lab."
            }
          ],
          "conclusion": "(-A3 -> A4)",
          "natural": "If it is not the case that the research lab has funding for project alpha, then the research lab receives a grant from the government agency."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-A3 -> A4)",
              "prover9_expression": "(-has_funding(research_lab, project_alpha) -> receives_grant(research_lab, government_agency))",
              "natural": "If it is not the case that the research lab has funding for project alpha, then the research lab receives a grant from the government agency."
            },
            {
              "id": "Rule45",
              "prover9": "(-A3 -> -A4)",
              "prover9_expression": "(-has_funding(research_lab, project_alpha) -> -receives_grant(research_lab, government_agency))",
              "natural": "In case it is not the case that the research lab has funding for project alpha, then it is not the case that the research lab receives a grant from the government agency."
            }
          ],
          "conclusion": "A3",
          "natural": "The research lab has funding for project alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule16",
              "prover9": "(A3 -> (A1 | A2))",
              "prover9_expression": "(has_funding(research_lab, project_alpha) -> (approved(clinical_trial, drug_x) | approved(clinical_trial, drug_y)))",
              "natural": "Provided that the research lab has funding for project alpha, then either drug X is approved for clinical trial or drug Y is approved for clinical trial."
            },
            {
              "id": "Derived",
              "prover9": "A3",
              "prover9_expression": "has_funding(research_lab, project_alpha)",
              "natural": "The research lab has funding for project alpha."
            }
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either drug X is approved for clinical trial, or drug Y is approved for clinical trial."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A1 | A2)",
              "prover9_expression": "(approved(clinical_trial, drug_x) | approved(clinical_trial, drug_y))",
              "natural": "Either drug X is approved for clinical trial, or drug Y is approved for clinical trial."
            },
            {
              "id": "Rule1",
              "prover9": "(A1 -> G)",
              "prover9_expression": "(approved(clinical_trial, drug_x) -> approved_for_market(drug_x))",
              "natural": "If drug X is approved for clinical trial, then drug X is approved for market."
            },
            {
              "id": "Rule8",
              "prover9": "(A2 -> G)",
              "prover9_expression": "(approved(clinical_trial, drug_y) -> approved_for_market(drug_x))",
              "natural": "Provided that drug Y is approved for clinical trial, drug X is approved for market."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule4",
              "prover9": "(A12 | A13)",
              "prover9_expression": "(files_patent(company_a, drug_x) | files_patent(company_b, drug_x))",
              "natural": "Either company A files a patent for drug X, or company B files a patent for drug X."
            },
            {
              "id": "Rule3",
              "prover9": "(A12 -> (-(A9 -> A8) -> A11))",
              "prover9_expression": "(files_patent(company_a, drug_x) -> (-(completes_phase_iii(drug_x) -> receives_fda_approval(drug_x)) -> initiates_appeal(fda_decision)))",
              "natural": "In case company A files a patent for drug X, then if it is not the case that drug X completing phase III leads to drug X receiving FDA approval, an appeal of the FDA decision is initiated."
            },
            {
              "id": "Rule5",
              "prover9": "(A13 -> (-(A9 -> A8) -> A11))",
              "prover9_expression": "(files_patent(company_b, drug_x) -> (-(completes_phase_iii(drug_x) -> receives_fda_approval(drug_x)) -> initiates_appeal(fda_decision)))",
              "natural": "Assuming company B files a patent for drug X, then if it is not the case that drug X completing phase III implies drug X receives FDA approval, an appeal of the FDA decision is initiated."
            }
          ],
          "conclusion": "(-(A9 -> A8) -> A11)",
          "natural": "If it is not the case that drug X completing phase III leads to drug X receiving FDA approval, then an appeal of the FDA decision is initiated."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A9 -> A8) -> A11)",
              "prover9_expression": "(-(completes_phase_iii(drug_x) -> receives_fda_approval(drug_x)) -> initiates_appeal(fda_decision))",
              "natural": "If it is not the case that drug X completing phase III leads to drug X receiving FDA approval, then an appeal of the FDA decision is initiated."
            },
            {
              "id": "Rule39",
              "prover9": "(-(A9 -> A8) -> -A11)",
              "prover9_expression": "(-(completes_phase_iii(drug_x) -> receives_fda_approval(drug_x)) -> -initiates_appeal(fda_decision))",
              "natural": "Assuming it is not the case that drug X completing phase III implies drug X receives FDA approval, then it is not the case that an appeal of the FDA decision is initiated."
            }
          ],
          "conclusion": "(A9 -> A8)",
          "natural": "Provided that drug X completes phase III, then drug X receives FDA approval."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A9 -> A8)",
              "prover9_expression": "(completes_phase_iii(drug_x) -> receives_fda_approval(drug_x))",
              "natural": "Provided that drug X completes phase III, then drug X receives FDA approval."
            },
            {
              "id": "Rule2",
              "prover9": "(A10 -> (A7 -> (A6 -> G)))",
              "prover9_expression": "(completes_phase_iii(drug_y) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "Provided that drug Y completes phase III, if drug X passes the efficacy test, then whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Rule34",
              "prover9": "(A9 | A10)",
              "prover9_expression": "(completes_phase_iii(drug_x) | completes_phase_iii(drug_y))",
              "natural": "Drug X completes phase III or drug Y completes phase III."
            }
          ],
          "conclusion": "(A8 | (A7 -> (A6 -> G)))",
          "natural": "Either drug X receives FDA approval, or if drug X passes the efficacy test, then whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | (A7 -> (A6 -> G)))",
              "prover9_expression": "(receives_fda_approval(drug_x) | (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "Either drug X receives FDA approval, or if drug X passes the efficacy test, then whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact19",
              "prover9": "-A8",
              "prover9_expression": "-receives_fda_approval(drug_x)",
              "natural": "It is not the case that drug X receives FDA approval."
            }
          ],
          "conclusion": "(A7 -> (A6 -> G))",
          "natural": "If drug X passes the efficacy test, then assuming drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 -> (A6 -> G))",
              "prover9_expression": "(passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))",
              "natural": "If drug X passes the efficacy test, then assuming drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact7",
              "prover9": "A7",
              "prover9_expression": "passes_efficacy_test(drug_x)",
              "natural": "Drug X passes the efficacy test."
            }
          ],
          "conclusion": "(A6 -> G)",
          "natural": "Whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A6 -> G)",
              "prover9_expression": "(passes_safety_test(drug_x) -> approved_for_market(drug_x))",
              "natural": "Whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact6",
              "prover9": "A6",
              "prover9_expression": "passes_safety_test(drug_x)",
              "natural": "Drug X passes the safety test."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule35",
              "prover9": "(-(A14 | G) -> A15)",
              "prover9_expression": "(-(passes_toxicity_test(drug_x) | approved_for_market(drug_x)) -> fails_toxicity_test(drug_x))",
              "natural": "If it is not the case that drug X passes the toxicity test or drug X is approved for market, then drug X fails the toxicity test."
            },
            {
              "id": "Fact9",
              "prover9": "-A15",
              "prover9_expression": "-fails_toxicity_test(drug_x)",
              "natural": "It is not the case that drug X fails the toxicity test."
            }
          ],
          "conclusion": "(A14 | G)",
          "natural": "Drug X passes the toxicity test or drug X is approved for market."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A14 | G)",
              "prover9_expression": "(passes_toxicity_test(drug_x) | approved_for_market(drug_x))",
              "natural": "Drug X passes the toxicity test or drug X is approved for market."
            },
            {
              "id": "Fact8",
              "prover9": "-A14",
              "prover9_expression": "-passes_toxicity_test(drug_x)",
              "natural": "It is not the case that drug X passes the toxicity test."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(A21 | (A19 -> -A18))",
              "prover9_expression": "(requests_extension(review_period) | (submits_additional_data(company_a) -> -delayed_approval(drug_x)))",
              "natural": "Either an extension of the review period is requested, or if company A submits additional data, then approval of drug X is not delayed."
            },
            {
              "id": "Fact11",
              "prover9": "-A21",
              "prover9_expression": "-requests_extension(review_period)",
              "natural": "It is not the case that an extension of the review period is requested."
            }
          ],
          "conclusion": "(A19 -> -A18)",
          "natural": "If company A submits additional data, then it is not the case that approval of drug X is delayed."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(A19 | A20)",
              "prover9_expression": "(submits_additional_data(company_a) | submits_additional_data(company_b))",
              "natural": "Company A submits additional data or company B submits additional data."
            },
            {
              "id": "Derived",
              "prover9": "(A19 -> -A18)",
              "prover9_expression": "(submits_additional_data(company_a) -> -delayed_approval(drug_x))",
              "natural": "If company A submits additional data, then it is not the case that approval of drug X is delayed."
            },
            {
              "id": "Rule9",
              "prover9": "(A20 -> -A18)",
              "prover9_expression": "(submits_additional_data(company_b) -> -delayed_approval(drug_x))",
              "natural": "In case company B submits additional data, then approval of drug X is not delayed."
            }
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that approval of drug X is delayed."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule6",
              "prover9": "(A17 -> A18)",
              "prover9_expression": "(receives_priority_status(drug_x) -> delayed_approval(drug_x))",
              "natural": "Whenever drug X receives priority status, approval of drug X is delayed."
            },
            {
              "id": "Derived",
              "prover9": "-A18",
              "prover9_expression": "-delayed_approval(drug_x)",
              "natural": "It is not the case that approval of drug X is delayed."
            }
          ],
          "conclusion": "-A17",
          "natural": "It is not the case that drug X receives priority status."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule44",
              "prover9": "(-(-G -> A16) -> A17)",
              "prover9_expression": "(-(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x)) -> receives_priority_status(drug_x))",
              "natural": "Provided that it is not the case that the negation of drug X being approved for market leads to drug X qualifying for expedited review, then drug X receives priority status."
            },
            {
              "id": "Derived",
              "prover9": "-A17",
              "prover9_expression": "-receives_priority_status(drug_x)",
              "natural": "It is not the case that drug X receives priority status."
            }
          ],
          "conclusion": "(-G -> A16)",
          "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A16)",
              "prover9_expression": "(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x))",
              "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
            },
            {
              "id": "Fact10",
              "prover9": "-A16",
              "prover9_expression": "-qualifies_expedited_review(drug_x)",
              "natural": "It is not the case that drug X qualifies for expedited review."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule13",
              "prover9": "(A24 -> (A23 -> A2))",
              "prover9_expression": "(has_collaboration(research_lab, company_a) -> (positive_results(clinical_trial, drug_y) -> approved(clinical_trial, drug_y)))",
              "natural": "Assuming the research lab has collaboration with company A, then if the clinical trial yields positive results for drug Y, drug Y is approved for clinical trial."
            },
            {
              "id": "Fact1",
              "prover9": "A24",
              "prover9_expression": "has_collaboration(research_lab, company_a)",
              "natural": "The research lab has collaboration with company A."
            }
          ],
          "conclusion": "(A23 -> A2)",
          "natural": "Provided that the clinical trial yields positive results for drug Y, drug Y is approved for clinical trial."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule11",
              "prover9": "(A22 -> A1)",
              "prover9_expression": "(positive_results(clinical_trial, drug_x) -> approved(clinical_trial, drug_x))",
              "natural": "If the clinical trial yields positive results for drug X, then drug X is approved for clinical trial."
            },
            {
              "id": "Derived",
              "prover9": "(A23 -> A2)",
              "prover9_expression": "(positive_results(clinical_trial, drug_y) -> approved(clinical_trial, drug_y))",
              "natural": "Provided that the clinical trial yields positive results for drug Y, drug Y is approved for clinical trial."
            },
            {
              "id": "Rule12",
              "prover9": "(A22 | A23)",
              "prover9_expression": "(positive_results(clinical_trial, drug_x) | positive_results(clinical_trial, drug_y))",
              "natural": "The clinical trial yields positive results for drug X or the clinical trial yields positive results for drug Y."
            }
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either drug X is approved for clinical trial, or drug Y is approved for clinical trial."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A1 | A2)",
              "prover9_expression": "(approved(clinical_trial, drug_x) | approved(clinical_trial, drug_y))",
              "natural": "Either drug X is approved for clinical trial, or drug Y is approved for clinical trial."
            },
            {
              "id": "Rule1",
              "prover9": "(A1 -> G)",
              "prover9_expression": "(approved(clinical_trial, drug_x) -> approved_for_market(drug_x))",
              "natural": "If drug X is approved for clinical trial, then drug X is approved for market."
            },
            {
              "id": "Rule8",
              "prover9": "(A2 -> G)",
              "prover9_expression": "(approved(clinical_trial, drug_y) -> approved_for_market(drug_x))",
              "natural": "Provided that drug Y is approved for clinical trial, drug X is approved for market."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule14",
              "prover9": "(A26 -> (A25 | A3))",
              "prover9_expression": "(has_partnership(company_a, research_lab) -> (secures_investment(company_a) | has_funding(research_lab, project_alpha)))",
              "natural": "In case company A has a partnership with the research lab, then either company A secures investment or the research lab has funding for project alpha."
            },
            {
              "id": "Fact2",
              "prover9": "A26",
              "prover9_expression": "has_partnership(company_a, research_lab)",
              "natural": "Company A has a partnership with the research lab."
            }
          ],
          "conclusion": "(A25 | A3)",
          "natural": "Either company A secures investment, or the research lab has funding for project alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A25 | A3)",
              "prover9_expression": "(secures_investment(company_a) | has_funding(research_lab, project_alpha))",
              "natural": "Either company A secures investment, or the research lab has funding for project alpha."
            },
            {
              "id": "Fact12",
              "prover9": "-A25",
              "prover9_expression": "-secures_investment(company_a)",
              "natural": "It is not the case that company A secures investment."
            }
          ],
          "conclusion": "A3",
          "natural": "The research lab has funding for project alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule16",
              "prover9": "(A3 -> (A1 | A2))",
              "prover9_expression": "(has_funding(research_lab, project_alpha) -> (approved(clinical_trial, drug_x) | approved(clinical_trial, drug_y)))",
              "natural": "Provided that the research lab has funding for project alpha, then either drug X is approved for clinical trial or drug Y is approved for clinical trial."
            },
            {
              "id": "Derived",
              "prover9": "A3",
              "prover9_expression": "has_funding(research_lab, project_alpha)",
              "natural": "The research lab has funding for project alpha."
            }
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either drug X is approved for clinical trial, or drug Y is approved for clinical trial."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A1 | A2)",
              "prover9_expression": "(approved(clinical_trial, drug_x) | approved(clinical_trial, drug_y))",
              "natural": "Either drug X is approved for clinical trial, or drug Y is approved for clinical trial."
            },
            {
              "id": "Rule1",
              "prover9": "(A1 -> G)",
              "prover9_expression": "(approved(clinical_trial, drug_x) -> approved_for_market(drug_x))",
              "natural": "If drug X is approved for clinical trial, then drug X is approved for market."
            },
            {
              "id": "Rule8",
              "prover9": "(A2 -> G)",
              "prover9_expression": "(approved(clinical_trial, drug_y) -> approved_for_market(drug_x))",
              "natural": "Provided that drug Y is approved for clinical trial, drug X is approved for market."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 4,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule40",
              "prover9": "(-(-(A6 -> G) -> A27) -> A28)",
              "prover9_expression": "(-(-(passes_safety_test(drug_x) -> approved_for_market(drug_x)) -> requires_retesting(drug_x)) -> waives_retesting_requirement(drug_x))",
              "natural": "Provided that it is not the case that the negation of drug X passing the safety test implying approval leads to drug X requiring retesting, then the retesting requirement for drug X is waived."
            },
            {
              "id": "Rule41",
              "prover9": "(-(-(A6 -> G) -> A27) -> -A28)",
              "prover9_expression": "(-(-(passes_safety_test(drug_x) -> approved_for_market(drug_x)) -> requires_retesting(drug_x)) -> -waives_retesting_requirement(drug_x))",
              "natural": "If it is not the case that the negation of drug X passing the safety test implying approval leads to drug X requiring retesting, then it is not the case that the retesting requirement for drug X is waived."
            }
          ],
          "conclusion": "(-(A6 -> G) -> A27)",
          "natural": "In case it is not the case that drug X passing the safety test implies drug X is approved for market, then drug X requires retesting."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A6 -> G) -> A27)",
              "prover9_expression": "(-(passes_safety_test(drug_x) -> approved_for_market(drug_x)) -> requires_retesting(drug_x))",
              "natural": "In case it is not the case that drug X passing the safety test implies drug X is approved for market, then drug X requires retesting."
            },
            {
              "id": "Fact13",
              "prover9": "-A27",
              "prover9_expression": "-requires_retesting(drug_x)",
              "natural": "It is not the case that drug X requires retesting."
            }
          ],
          "conclusion": "(A6 -> G)",
          "natural": "Whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A6 -> G)",
              "prover9_expression": "(passes_safety_test(drug_x) -> approved_for_market(drug_x))",
              "natural": "Whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact6",
              "prover9": "A6",
              "prover9_expression": "passes_safety_test(drug_x)",
              "natural": "Drug X passes the safety test."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 4,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule36",
              "prover9": "(-(A29 -> (A6 -> G)) -> A31)",
              "prover9_expression": "(-(meets_manufacturing_standards(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))) -> fails_manufacturing_audit(drug_x))",
              "natural": "In case it is not the case that drug X meeting manufacturing standards leads to drug X being approved for market under safety, then drug X fails the manufacturing audit."
            },
            {
              "id": "Fact14",
              "prover9": "-A31",
              "prover9_expression": "-fails_manufacturing_audit(drug_x)",
              "natural": "It is not the case that drug X fails the manufacturing audit."
            }
          ],
          "conclusion": "(A29 -> (A6 -> G))",
          "natural": "If drug X meets manufacturing standards, then whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule15",
              "prover9": "(A29 | A30)",
              "prover9_expression": "(meets_manufacturing_standards(drug_x) | meets_manufacturing_standards(drug_y))",
              "natural": "Drug X meets manufacturing standards or drug Y meets manufacturing standards."
            },
            {
              "id": "Derived",
              "prover9": "(A29 -> (A6 -> G))",
              "prover9_expression": "(meets_manufacturing_standards(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))",
              "natural": "If drug X meets manufacturing standards, then whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Rule17",
              "prover9": "(A30 -> (A6 -> G))",
              "prover9_expression": "(meets_manufacturing_standards(drug_y) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))",
              "natural": "Assuming drug Y meets manufacturing standards, then if drug X passes the safety test, drug X is approved for market."
            }
          ],
          "conclusion": "(A6 -> G)",
          "natural": "Whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A6 -> G)",
              "prover9_expression": "(passes_safety_test(drug_x) -> approved_for_market(drug_x))",
              "natural": "Whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact6",
              "prover9": "A6",
              "prover9_expression": "passes_safety_test(drug_x)",
              "natural": "Drug X passes the safety test."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule21",
              "prover9": "(A34 -> A35)",
              "prover9_expression": "(passes_quality_control(drug_x) -> passes_quality_control(drug_y))",
              "natural": "Whenever drug X passes quality control, drug Y passes quality control."
            },
            {
              "id": "Rule22",
              "prover9": "(A35 -> (A7 -> (A6 -> G)))",
              "prover9_expression": "(passes_quality_control(drug_y) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "Provided that drug Y passes quality control, then if drug X passes the efficacy test, whenever drug X passes the safety test, drug X is approved for market."
            }
          ],
          "conclusion": "(A34 -> (A7 -> (A6 -> G)))",
          "natural": "If drug X passes quality control, then assuming drug X passes the efficacy test, if drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule20",
              "prover9": "(A33 -> A34)",
              "prover9_expression": "(completes_stability_study(drug_y) -> passes_quality_control(drug_x))",
              "natural": "In case drug Y completes the stability study, then drug X passes quality control."
            },
            {
              "id": "Derived",
              "prover9": "(A34 -> (A7 -> (A6 -> G)))",
              "prover9_expression": "(passes_quality_control(drug_x) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "If drug X passes quality control, then assuming drug X passes the efficacy test, if drug X passes the safety test, drug X is approved for market."
            }
          ],
          "conclusion": "(A33 -> (A7 -> (A6 -> G)))",
          "natural": "Provided that drug Y completes the stability study, then if drug X passes the efficacy test, whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule18",
              "prover9": "(A32 -> A8)",
              "prover9_expression": "(completes_stability_study(drug_x) -> receives_fda_approval(drug_x))",
              "natural": "If drug X completes the stability study, then drug X receives FDA approval."
            },
            {
              "id": "Derived",
              "prover9": "(A33 -> (A7 -> (A6 -> G)))",
              "prover9_expression": "(completes_stability_study(drug_y) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "Provided that drug Y completes the stability study, then if drug X passes the efficacy test, whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Rule19",
              "prover9": "(A32 | A33)",
              "prover9_expression": "(completes_stability_study(drug_x) | completes_stability_study(drug_y))",
              "natural": "Either drug X completes the stability study, or drug Y completes the stability study."
            }
          ],
          "conclusion": "(A8 | (A7 -> (A6 -> G)))",
          "natural": "Either drug X receives FDA approval, or if drug X passes the efficacy test, then whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | (A7 -> (A6 -> G)))",
              "prover9_expression": "(receives_fda_approval(drug_x) | (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "Either drug X receives FDA approval, or if drug X passes the efficacy test, then whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact19",
              "prover9": "-A8",
              "prover9_expression": "-receives_fda_approval(drug_x)",
              "natural": "It is not the case that drug X receives FDA approval."
            }
          ],
          "conclusion": "(A7 -> (A6 -> G))",
          "natural": "If drug X passes the efficacy test, then assuming drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 -> (A6 -> G))",
              "prover9_expression": "(passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))",
              "natural": "If drug X passes the efficacy test, then assuming drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact7",
              "prover9": "A7",
              "prover9_expression": "passes_efficacy_test(drug_x)",
              "natural": "Drug X passes the efficacy test."
            }
          ],
          "conclusion": "(A6 -> G)",
          "natural": "Whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A6 -> G)",
              "prover9_expression": "(passes_safety_test(drug_x) -> approved_for_market(drug_x))",
              "natural": "Whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact6",
              "prover9": "A6",
              "prover9_expression": "passes_safety_test(drug_x)",
              "natural": "Drug X passes the safety test."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 10,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule25",
              "prover9": "(A39 | (-(A37 -> (A7 -> (A6 -> G))) -> A38))",
              "prover9_expression": "(accepts_regulatory_submission(agency) | (-(completes_bioequivalence_study(drug_y) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))) -> initiates_reformulation(drug_x)))",
              "natural": "Either the agency accepts the regulatory submission, or if it is not the case that drug Y completing the bioequivalence study leads to drug X being approved for market under efficacy and safety, then reformulation of drug X is initiated."
            },
            {
              "id": "Fact15",
              "prover9": "-A39",
              "prover9_expression": "-accepts_regulatory_submission(agency)",
              "natural": "It is not the case that the agency accepts the regulatory submission."
            }
          ],
          "conclusion": "(-(A37 -> (A7 -> (A6 -> G))) -> A38)",
          "natural": "Assuming it is not the case that drug Y completing the bioequivalence study implies drug X is approved for market under efficacy and safety, then reformulation of drug X is initiated."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A37 -> (A7 -> (A6 -> G))) -> A38)",
              "prover9_expression": "(-(completes_bioequivalence_study(drug_y) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))) -> initiates_reformulation(drug_x))",
              "natural": "Assuming it is not the case that drug Y completing the bioequivalence study implies drug X is approved for market under efficacy and safety, then reformulation of drug X is initiated."
            },
            {
              "id": "Rule37",
              "prover9": "(-(A37 -> (A7 -> (A6 -> G))) -> -A38)",
              "prover9_expression": "(-(completes_bioequivalence_study(drug_y) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))) -> -initiates_reformulation(drug_x))",
              "natural": "If it is not the case that drug Y completing the bioequivalence study leads to drug X being approved for market under efficacy and safety, then it is not the case that reformulation of drug X is initiated."
            }
          ],
          "conclusion": "(A37 -> (A7 -> (A6 -> G)))",
          "natural": "Assuming drug Y completes the bioequivalence study, then if drug X passes the efficacy test, provided that drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule23",
              "prover9": "(A36 -> A8)",
              "prover9_expression": "(completes_bioequivalence_study(drug_x) -> receives_fda_approval(drug_x))",
              "natural": "If drug X completes the bioequivalence study, then drug X receives FDA approval."
            },
            {
              "id": "Derived",
              "prover9": "(A37 -> (A7 -> (A6 -> G)))",
              "prover9_expression": "(completes_bioequivalence_study(drug_y) -> (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "Assuming drug Y completes the bioequivalence study, then if drug X passes the efficacy test, provided that drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Rule24",
              "prover9": "(A36 | A37)",
              "prover9_expression": "(completes_bioequivalence_study(drug_x) | completes_bioequivalence_study(drug_y))",
              "natural": "Either drug X completes the bioequivalence study, or drug Y completes the bioequivalence study."
            }
          ],
          "conclusion": "(A8 | (A7 -> (A6 -> G)))",
          "natural": "Either drug X receives FDA approval, or if drug X passes the efficacy test, then whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | (A7 -> (A6 -> G)))",
              "prover9_expression": "(receives_fda_approval(drug_x) | (passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x))))",
              "natural": "Either drug X receives FDA approval, or if drug X passes the efficacy test, then whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact19",
              "prover9": "-A8",
              "prover9_expression": "-receives_fda_approval(drug_x)",
              "natural": "It is not the case that drug X receives FDA approval."
            }
          ],
          "conclusion": "(A7 -> (A6 -> G))",
          "natural": "If drug X passes the efficacy test, then assuming drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 -> (A6 -> G))",
              "prover9_expression": "(passes_efficacy_test(drug_x) -> (passes_safety_test(drug_x) -> approved_for_market(drug_x)))",
              "natural": "If drug X passes the efficacy test, then assuming drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact7",
              "prover9": "A7",
              "prover9_expression": "passes_efficacy_test(drug_x)",
              "natural": "Drug X passes the efficacy test."
            }
          ],
          "conclusion": "(A6 -> G)",
          "natural": "Whenever drug X passes the safety test, drug X is approved for market."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A6 -> G)",
              "prover9_expression": "(passes_safety_test(drug_x) -> approved_for_market(drug_x))",
              "natural": "Whenever drug X passes the safety test, drug X is approved for market."
            },
            {
              "id": "Fact6",
              "prover9": "A6",
              "prover9_expression": "passes_safety_test(drug_x)",
              "natural": "Drug X passes the safety test."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 11,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule26",
              "prover9": "(A40 -> A41)",
              "prover9_expression": "(has_gmp_certification(facility_a) -> has_gmp_certification(facility_b))",
              "natural": "If facility A has GMP certification, then facility B has GMP certification."
            },
            {
              "id": "Rule27",
              "prover9": "(A41 -> (A14 | G))",
              "prover9_expression": "(has_gmp_certification(facility_b) -> (passes_toxicity_test(drug_x) | approved_for_market(drug_x)))",
              "natural": "Provided that facility B has GMP certification, then drug X passes the toxicity test or drug X is approved for market."
            }
          ],
          "conclusion": "(A40 -> (A14 | G))",
          "natural": "In case facility A has GMP certification, then either drug X passes the toxicity test or drug X is approved for market."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A40 -> (A14 | G))",
              "prover9_expression": "(has_gmp_certification(facility_a) -> (passes_toxicity_test(drug_x) | approved_for_market(drug_x)))",
              "natural": "In case facility A has GMP certification, then either drug X passes the toxicity test or drug X is approved for market."
            },
            {
              "id": "Fact3",
              "prover9": "A40",
              "prover9_expression": "has_gmp_certification(facility_a)",
              "natural": "Facility A has GMP certification."
            }
          ],
          "conclusion": "(A14 | G)",
          "natural": "Drug X passes the toxicity test or drug X is approved for market."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A14 | G)",
              "prover9_expression": "(passes_toxicity_test(drug_x) | approved_for_market(drug_x))",
              "natural": "Drug X passes the toxicity test or drug X is approved for market."
            },
            {
              "id": "Fact8",
              "prover9": "-A14",
              "prover9_expression": "-passes_toxicity_test(drug_x)",
              "natural": "It is not the case that drug X passes the toxicity test."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 12,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule29",
              "prover9": "(A43 -> A42)",
              "prover9_expression": "(submits_dossier(company_a) -> provides_clinical_data(company_a))",
              "natural": "If company A submits a dossier, then company A provides clinical data."
            },
            {
              "id": "Fact4",
              "prover9": "A43",
              "prover9_expression": "submits_dossier(company_a)",
              "natural": "Company A submits a dossier."
            }
          ],
          "conclusion": "A42",
          "natural": "Company A provides clinical data."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule28",
              "prover9": "(A42 -> -A18)",
              "prover9_expression": "(provides_clinical_data(company_a) -> -delayed_approval(drug_x))",
              "natural": "Whenever company A provides clinical data, then it is not the case that approval of drug X is delayed."
            },
            {
              "id": "Derived",
              "prover9": "A42",
              "prover9_expression": "provides_clinical_data(company_a)",
              "natural": "Company A provides clinical data."
            }
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that approval of drug X is delayed."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule6",
              "prover9": "(A17 -> A18)",
              "prover9_expression": "(receives_priority_status(drug_x) -> delayed_approval(drug_x))",
              "natural": "Whenever drug X receives priority status, approval of drug X is delayed."
            },
            {
              "id": "Derived",
              "prover9": "-A18",
              "prover9_expression": "-delayed_approval(drug_x)",
              "natural": "It is not the case that approval of drug X is delayed."
            }
          ],
          "conclusion": "-A17",
          "natural": "It is not the case that drug X receives priority status."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule44",
              "prover9": "(-(-G -> A16) -> A17)",
              "prover9_expression": "(-(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x)) -> receives_priority_status(drug_x))",
              "natural": "Provided that it is not the case that the negation of drug X being approved for market leads to drug X qualifying for expedited review, then drug X receives priority status."
            },
            {
              "id": "Derived",
              "prover9": "-A17",
              "prover9_expression": "-receives_priority_status(drug_x)",
              "natural": "It is not the case that drug X receives priority status."
            }
          ],
          "conclusion": "(-G -> A16)",
          "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A16)",
              "prover9_expression": "(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x))",
              "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
            },
            {
              "id": "Fact10",
              "prover9": "-A16",
              "prover9_expression": "-qualifies_expedited_review(drug_x)",
              "natural": "It is not the case that drug X qualifies for expedited review."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 13,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule32",
              "prover9": "(A47 | (A45 -> A44))",
              "prover9_expression": "(requests_advisory_meeting(company_a) | (submits_dossier(company_b) -> provides_clinical_data(company_b)))",
              "natural": "Either company A requests an advisory meeting, or if company B submits a dossier, then company B provides clinical data."
            },
            {
              "id": "Fact17",
              "prover9": "-A47",
              "prover9_expression": "-requests_advisory_meeting(company_a)",
              "natural": "It is not the case that company A requests an advisory meeting."
            }
          ],
          "conclusion": "(A45 -> A44)",
          "natural": "Assuming company B submits a dossier, then company B provides clinical data."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A45 -> A44)",
              "prover9_expression": "(submits_dossier(company_b) -> provides_clinical_data(company_b))",
              "natural": "Assuming company B submits a dossier, then company B provides clinical data."
            },
            {
              "id": "Rule31",
              "prover9": "(A46 -> -A18)",
              "prover9_expression": "(provides_additional_analysis(company_b) -> -delayed_approval(drug_x))",
              "natural": "In case company B provides additional analysis, then approval of drug X is not delayed."
            },
            {
              "id": "Rule30",
              "prover9": "(A45 | A46)",
              "prover9_expression": "(submits_dossier(company_b) | provides_additional_analysis(company_b))",
              "natural": "Company B submits a dossier or company B provides additional analysis."
            }
          ],
          "conclusion": "(A44 | -A18)",
          "natural": "Either company B provides clinical data, or approval of drug X is not delayed."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A44 | -A18)",
              "prover9_expression": "(provides_clinical_data(company_b) | -delayed_approval(drug_x))",
              "natural": "Either company B provides clinical data, or approval of drug X is not delayed."
            },
            {
              "id": "Fact16",
              "prover9": "-A44",
              "prover9_expression": "-provides_clinical_data(company_b)",
              "natural": "It is not the case that company B provides clinical data."
            }
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that approval of drug X is delayed."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule6",
              "prover9": "(A17 -> A18)",
              "prover9_expression": "(receives_priority_status(drug_x) -> delayed_approval(drug_x))",
              "natural": "Whenever drug X receives priority status, approval of drug X is delayed."
            },
            {
              "id": "Derived",
              "prover9": "-A18",
              "prover9_expression": "-delayed_approval(drug_x)",
              "natural": "It is not the case that approval of drug X is delayed."
            }
          ],
          "conclusion": "-A17",
          "natural": "It is not the case that drug X receives priority status."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule44",
              "prover9": "(-(-G -> A16) -> A17)",
              "prover9_expression": "(-(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x)) -> receives_priority_status(drug_x))",
              "natural": "Provided that it is not the case that the negation of drug X being approved for market leads to drug X qualifying for expedited review, then drug X receives priority status."
            },
            {
              "id": "Derived",
              "prover9": "-A17",
              "prover9_expression": "-receives_priority_status(drug_x)",
              "natural": "It is not the case that drug X receives priority status."
            }
          ],
          "conclusion": "(-G -> A16)",
          "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A16)",
              "prover9_expression": "(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x))",
              "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
            },
            {
              "id": "Fact10",
              "prover9": "-A16",
              "prover9_expression": "-qualifies_expedited_review(drug_x)",
              "natural": "It is not the case that drug X qualifies for expedited review."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    },
    {
      "id": 14,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule38",
              "prover9": "(-(A49 -> A48) -> A50)",
              "prover9_expression": "(-(receives_deficiency_letter(company_a) -> responds_to_deficiency_letter(company_a)) -> faces_regulatory_sanctions(company_a))",
              "natural": "Provided that it is not the case that company A receiving a deficiency letter leads to company A responding to the deficiency letter, then company A faces regulatory sanctions."
            },
            {
              "id": "Fact18",
              "prover9": "-A50",
              "prover9_expression": "-faces_regulatory_sanctions(company_a)",
              "natural": "It is not the case that company A faces regulatory sanctions."
            }
          ],
          "conclusion": "(A49 -> A48)",
          "natural": "If company A receives a deficiency letter, then company A responds to the deficiency letter."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A49 -> A48)",
              "prover9_expression": "(receives_deficiency_letter(company_a) -> responds_to_deficiency_letter(company_a))",
              "natural": "If company A receives a deficiency letter, then company A responds to the deficiency letter."
            },
            {
              "id": "Fact5",
              "prover9": "A49",
              "prover9_expression": "receives_deficiency_letter(company_a)",
              "natural": "Company A receives a deficiency letter."
            }
          ],
          "conclusion": "A48",
          "natural": "Company A responds to the deficiency letter."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule33",
              "prover9": "(A48 -> (A19 -> -A18))",
              "prover9_expression": "(responds_to_deficiency_letter(company_a) -> (submits_additional_data(company_a) -> -delayed_approval(drug_x)))",
              "natural": "Provided that company A responds to the deficiency letter, then if company A submits additional data, approval of drug X is not delayed."
            },
            {
              "id": "Derived",
              "prover9": "A48",
              "prover9_expression": "responds_to_deficiency_letter(company_a)",
              "natural": "Company A responds to the deficiency letter."
            }
          ],
          "conclusion": "(A19 -> -A18)",
          "natural": "If company A submits additional data, then it is not the case that approval of drug X is delayed."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(A19 | A20)",
              "prover9_expression": "(submits_additional_data(company_a) | submits_additional_data(company_b))",
              "natural": "Company A submits additional data or company B submits additional data."
            },
            {
              "id": "Derived",
              "prover9": "(A19 -> -A18)",
              "prover9_expression": "(submits_additional_data(company_a) -> -delayed_approval(drug_x))",
              "natural": "If company A submits additional data, then it is not the case that approval of drug X is delayed."
            },
            {
              "id": "Rule9",
              "prover9": "(A20 -> -A18)",
              "prover9_expression": "(submits_additional_data(company_b) -> -delayed_approval(drug_x))",
              "natural": "In case company B submits additional data, then approval of drug X is not delayed."
            }
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that approval of drug X is delayed."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule6",
              "prover9": "(A17 -> A18)",
              "prover9_expression": "(receives_priority_status(drug_x) -> delayed_approval(drug_x))",
              "natural": "Whenever drug X receives priority status, approval of drug X is delayed."
            },
            {
              "id": "Derived",
              "prover9": "-A18",
              "prover9_expression": "-delayed_approval(drug_x)",
              "natural": "It is not the case that approval of drug X is delayed."
            }
          ],
          "conclusion": "-A17",
          "natural": "It is not the case that drug X receives priority status."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule44",
              "prover9": "(-(-G -> A16) -> A17)",
              "prover9_expression": "(-(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x)) -> receives_priority_status(drug_x))",
              "natural": "Provided that it is not the case that the negation of drug X being approved for market leads to drug X qualifying for expedited review, then drug X receives priority status."
            },
            {
              "id": "Derived",
              "prover9": "-A17",
              "prover9_expression": "-receives_priority_status(drug_x)",
              "natural": "It is not the case that drug X receives priority status."
            }
          ],
          "conclusion": "(-G -> A16)",
          "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A16)",
              "prover9_expression": "(-approved_for_market(drug_x) -> qualifies_expedited_review(drug_x))",
              "natural": "Whenever it is not the case that drug X is approved for market, then drug X qualifies for expedited review."
            },
            {
              "id": "Fact10",
              "prover9": "-A16",
              "prover9_expression": "-qualifies_expedited_review(drug_x)",
              "natural": "It is not the case that drug X qualifies for expedited review."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is approved for market."
        }
      ]
    }
  ]
}